P74 Ventures

P74 Ventures is uniquely positioned to be the “Flagship Pioneering” for the Pharma-Tech venture community -- focused on both founding and investing in technology companies that drive innovation and business model transformation within the $1.5 trillion life sciences industry. While most healthcare VCs focus on either biotech or the broader digital health landscape, few, if any, have the expertise to invest in the enabling technologies that drive the business & operations of pharma. Even fewer, have the ability to also co-found companies targeting the core challenges in this space. Together, P74’s Managing Partners have been at the forefront of pharma’s innovation efforts for the last decade – starting companies and then leading digital investments, global innovation, business model transformation, strategic corporate partnerships, and data science and AI at the #3 pharma company in the world, Novartis. As leading experts in the field, P74’s Fund Managers believe they can continue to achieve alpha returns by investing in and/or co-founding early-stage companies targeting problems and markets where the Team has deep experience and where at least one pharma will be a founding partner, paying customer, and/or co-development collaborator. Over the last few years alone, the team has completed 26 investments (with 3 IPOs/SPACs), founded 3 companies (with 2 PE exits), led partnerships with over 85 startups and industry-leading tech companies, and developed 8 transformational technology platforms for big-pharma.